Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 30, 2026
Reporting period
Not applicable
Filed with the SEC
May 1, 2026
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0002070664-26-000005
Filed / recorded
May 1, 2026, 12:33 AM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SHOULDER INNOVATIONS, INC.
Issuer CIK
1699350
Ticker
SI
Reporting person
Robert Joseph Ball
Relationship
Director, Officer
Officer title
CEO & Executive Chairman
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Apr 30, 2026
Transaction code
M
Shares / units
10,000
Price per share
$2.48
Acquired / disposed
Acquired (A)
Shares owned after
300,018
Ownership form
Direct
Amendment
No
Footnotes from the filing
Includes the following shares received without consideration as in-kind distributions: (i) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (ii) 6,752 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock held directly.